EGFR-independent Elk1/CIP2A signalling mediates apoptotic effect of an erlotinib derivative TD52 in triple-negative breast cancer cells. [electronic resource]
Producer: 20170809Description: 112-123 p. digitalISSN:- 1879-0852
- Animals
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Autoantigens -- genetics
- Disease Models, Animal
- ErbB Receptors -- metabolism
- Erlotinib Hydrochloride -- pharmacology
- Heterografts
- Humans
- Intracellular Signaling Peptides and Proteins
- Membrane Proteins -- genetics
- Mice
- Mice, Nude
- RNA, Messenger -- metabolism
- Signal Transduction -- drug effects
- Triple Negative Breast Neoplasms -- drug therapy
- Tumor Cells, Cultured
- ets-Domain Protein Elk-1 -- genetics
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.